NEURODEGENERATIVE CLINICAL RESEARCH IN 2024: ALS, DEMENTIA, MYSTHANIA GRAVIS, DEMENTIA, ALZHEIMER’S, HUTTINGTON
Introduction Neurodegenerative diseases encompass a group of disorders characterized by neuronal loss and progressive degeneration of the nervous system, posing a significant global health challenge with increasing incidence rates (Sumera et al., 2023). These diseases, such as Alzheimer’s, Parkinson’s, Huntington’s, amyotrophic lateral sclerosis (ALS), and Multiple sclerosis, are multifactorial conditions often associated with gene mutations …